JHCP
Jackson Hole Capital Partners’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.33M | Sell |
6,002
-1
| -0% | -$389 | 0.43% | 73 |
|
2025
Q1 | $2.61M | Sell |
6,003
-26
| -0.4% | -$11.3K | 0.52% | 60 |
|
2024
Q4 | $2.22M | Sell |
6,029
-133
| -2% | -$49.1K | 0.45% | 66 |
|
2024
Q3 | $3.2M | Buy |
6,162
+43
| +0.7% | +$22.4K | 0.67% | 42 |
|
2024
Q2 | $3.32M | Buy |
6,119
+55
| +0.9% | +$29.8K | 0.72% | 36 |
|
2024
Q1 | $3.14M | Buy |
6,064
+393
| +7% | +$204K | 0.71% | 38 |
|
2023
Q4 | $2.67M | Buy |
5,671
+650
| +13% | +$307K | 0.68% | 37 |
|
2023
Q3 | $2.19M | Sell |
5,021
-166
| -3% | -$72.3K | 0.64% | 40 |
|
2023
Q2 | $2.3M | Sell |
5,187
-489
| -9% | -$217K | 0.63% | 40 |
|
2023
Q1 | $2.62M | Buy |
5,676
+430
| +8% | +$198K | 0.69% | 38 |
|
2022
Q4 | $2.69M | Sell |
5,246
-181
| -3% | -$92.8K | 0.8% | 35 |
|
2022
Q3 | $2.47M | Buy |
5,427
+75
| +1% | +$34.1K | 0.76% | 37 |
|
2022
Q2 | $2.58M | Sell |
5,352
-87
| -2% | -$42K | 0.81% | 36 |
|
2022
Q1 | $2.67M | Buy |
5,439
+173
| +3% | +$85K | 0.77% | 38 |
|
2021
Q4 | $2.44M | Sell |
5,266
-161
| -3% | -$74.6K | 0.76% | 38 |
|
2021
Q3 | $2.02M | Buy |
5,427
+296
| +6% | +$110K | 0.66% | 50 |
|
2021
Q2 | $1.96M | Buy |
5,131
+58
| +1% | +$22.1K | 0.68% | 48 |
|
2021
Q1 | $1.82M | Buy |
5,073
+249
| +5% | +$89.4K | 0.75% | 42 |
|
2020
Q4 | $1.55M | Buy |
4,824
+279
| +6% | +$89.6K | 0.71% | 47 |
|
2020
Q3 | $1.22M | Buy |
4,545
+259
| +6% | +$69.6K | 0.64% | 51 |
|
2020
Q2 | $1.13M | Buy |
4,286
+219
| +5% | +$57.6K | 0.69% | 46 |
|
2020
Q1 | $923K | Buy |
+4,067
| New | +$923K | 0.69% | 51 |
|